BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6225980)

  • 1. Dental management of the classic hemophiliac with inhibitors.
    Redding SW; Stiegler KE
    Oral Surg Oral Med Oral Pathol; 1983 Aug; 56(2):145-8. PubMed ID: 6225980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance of hemostasis during exodontia in two hemophiliacs with factor VIII inhibitors.
    Zech R; Strother SV
    J Oral Maxillofac Surg; 1983 Jan; 41(1):53-6. PubMed ID: 6217303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Poly-electrolyte fractionated porcine factor VIII in the treatment of hemophilia A].
    Ferencz T; Skopál J; Csáki C; Laczkó M; Schuler D; Borsi J
    Orv Hetil; 1993 Dec; 134(52):2873-5. PubMed ID: 8272354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of dental extractions in two hemophilia A patients with factor VIII inhibitor.
    Shurafa M; MacIntosh RB
    J Oral Maxillofac Surg; 1987 Aug; 45(8):698-701. PubMed ID: 2956401
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of activated prothrombin complex concentrate in a severely hemophilic patient with Factor VIII inhibitor.
    Garehime WJ; Pecaro BC; Green D
    J Oral Maxillofac Surg; 1983 Apr; 41(4):262-4. PubMed ID: 6220139
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of anti-factor VIII antibodies.
    Blatt PM; White GC; McMillan CW; Roberts HR
    Thromb Haemost; 1977 Aug; 38(2):514-23. PubMed ID: 579493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitor antibodies to factor VIII and factor IX: management.
    Lusher JM
    Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Factor VIII epitopes recognized by inhibitors in hemophiliacs].
    Hayashi T; Niiya K; Sakuragawa N; Ichihara K; Yamazaki T; Watanabe A
    Rinsho Ketsueki; 1991 Sep; 32(9):945-50. PubMed ID: 1719257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia A mice compared with factor VIII protein infusion.
    Bristol JA; Gallo-Penn A; Andrews J; Idamakanti N; Kaleko M; Connelly S
    Hum Gene Ther; 2001 Sep; 12(13):1651-61. PubMed ID: 11535168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dental extraction in a patient with congenital deficiencies of factors V and VIII.
    Takeuchi M; Shikimori M; Kaneda T
    J Oral Maxillofac Surg; 1984 May; 42(5):327-30. PubMed ID: 6232358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful peritoneal dialysis in a hemophilia A patient with factor VIII inhibitor.
    Solak Y; Turkmen K; Atalay H; Turk S
    Perit Dial Int; 2010; 30(1):114-6. PubMed ID: 20056993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dental care for hemophilic patients. II. Consequences for dental practice].
    Ned Tijdschr Tandheelkd; 1982 May; 89(5):200-5. PubMed ID: 6213874
    [No Abstract]   [Full Text] [Related]  

  • 13. Surgery for a chronic cystic hematoma on the right thigh in a hemophiliac A with a potent factor VIII inhibitor.
    Masuhara K; Shimizu T; Kawasaki N; Fukui H; Sakai Y; Shima M; Mikami S; Yoshioka A
    Nihon Seikeigeka Gakkai Zasshi; 1982 Dec; 56(12):1719-27. PubMed ID: 6820658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophilia. Strategies for the treatment of inhibitor patients.
    Ingerslev J
    Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Problems in the dental treatment of a case of hemophilia A].
    Sakai M; Saito T; Ikeshima K; Kamata M; Yoshikawa T; Kaneko M; Kamioka H; Masujima J; Ikeda M; Sato H
    Tohoku Shika Daigaku Gakkai Shi; 1986 Mar; 13(1):37-43. PubMed ID: 2943645
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-A in factor VIII concentrate: a cause of severe hemolysis in a patient with acquired factor VIII:C antibodies.
    Hach-Wunderle V; Teixidor D; Zumpe P; Kühnl P; Scharrer I
    Infusionstherapie; 1989 Jun; 16(3):100-1. PubMed ID: 2503450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of anti-human and anti-porcine factor VIII antibody titers in patients with hemophilia].
    Windyga J; Rzymkiewicz L; Lopaciuk S
    Acta Haematol Pol; 1996; 27(1):27-31. PubMed ID: 8629440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fracture of the maxillary tuberosity in the hemophiliac patient].
    Duarte Ronces M; Hernández Cazares L; Gutiérrez Romero M
    Pract Odontol; 1990 Nov; 11(11):15-6, 18-20, 25. PubMed ID: 2151896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of activated prothrombin complex concentrates in a hemophiliac with an anti-factor VIII antibody.
    Blatt PM; White GC; McMillan CW; Webster WP
    JAMA; 1984 Jan; 251(1):67. PubMed ID: 6418898
    [No Abstract]   [Full Text] [Related]  

  • 20. Factor VIII inhibitors in previously treated haemophilia A patients with a double virus-inactivated plasma derived factor VIII concentrate.
    Peerlinck K; Arnout J; Di Giambattista M; Gilles JG; Laub R; Jacquemin M; Saint-Remy JM; Vermylen J
    Thromb Haemost; 1997 Jan; 77(1):80-6. PubMed ID: 9031454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.